2. Jean-Louis Vincent, MD, PhD
Professor of intensive care medicine
(University of Brussels)
Past-President, European Society of Intensive Care Medicine
Past-President, World Federation of Intensive and Critical Care Societies
SEPSIS
INITIAL RESUSCITATION
IN THE EMERGENCY DEPT
16. quickSOFA (qSOFA)
✓ Tachypnea (RR ≥ 22 breaths/min)
✓ Hypotension (systolic BP ≤100 mmHg)
✓ Altered Mentation
ALARM SIGNAL
to identify infected patients with poor outcomes
- additional tests to evaluate organ function
- prompt intervention
- increased surveillance / transfer to ICU?
18. ✓Circulatory
✓Respiratory
✓Renal
✓Hepatic
✓Neurological
✓Hematological
SEPSIS ?
ACUTE CHANGES IN ORGAN FUNCTION
hypotension, tachycardia
hyperlactatemia
disorientation, confusion
tachypnea, hypoxemia (low SpO2)
oliguria
increased creatinine levels
Icterus,
hyperbilirubinemia
low platelet count
If these acute changes are not explained by other factors than an infection
hypotension
tachypnea
altered
mentation
qSOFA
20. qSOFA SEPSIS INFECTION
qSOFA is NOT specific for sepsis
It could be severe heart failure, hypovolemia, pulmonary embolism…
✓ Tachypnea (RR ≥ 22 breaths/min)
✓ Hypotension (systolic BP ≤100 mmHg)
✓ Altered Mentation
21. Risk assessment of the blunt trauma victim:
The role of the quick Sequential Organ Failure
Assessment Score (qSOFA)
Jawa et al
22. Risk assessment of the blunt trauma victim:
The role of the quick Sequential Organ Failure
Assessment Score (qSOFA)
Jawa et al
23. Risk assessment of the blunt trauma victim:
The role of the quick Sequential Organ Failure
Assessment Score (qSOFA)
Jawa et al
24. Risk assessment of the blunt trauma victim:
The role of the quick Sequential Organ Failure
Assessment Score (qSOFA)
Jawa et al
35. e.g. septic shock
meningococcemia
e.g. possible
lung infection
(+ moderate OF)
SEVERITY
ANTIBIOTIC THERAPY IN SEPSIS
1
12
2
3
4
5
6
7
8
9
10
11
No waste
of time
36. e.g. septic shock
meningococcemia
e.g. possible
lung infection
(+ moderate OF)
SEVERITY
ANTIBIOTIC THERAPY IN SEPSIS
Urgently Very early Early
1
12
2
3
4
5
6
7
8
9
10
11
No waste
of time
37. e.g. septic shock
meningococcemia
e.g. possible
lung infection
(+ moderate OF)
SEVERITY
ANTIBIOTIC THERAPY IN SEPSIS
Urgently Very early Early
1
12
2
3
4
5
6
7
8
9
10
11
No waste
of time
Additional tests?
(BAL?)
Advise?
38. 2021
nationwide VA hospitals (N = 111,385 pts)
30 d mortality 12.4%
time-to-antibiotics for sepsis has declined over time
44. 2021
24,093 cases - 12 hospitals
OR for mortality
Recognition delay
Administration delay
45. What I tell the nurse
Give antibiotics without delay
in severe cases
How I treat septic shock
I motivate the team!
46. Conclusion:
Among patients with severe manifestations of sepsis,
initiation of empirical antimicrobial therapy significantly reduces
the sensitivity of blood cultures drawn shortly after treatment initiation.
Preantimicrobial blood cultures were positive in 102 of 325 (31.4%) patients.
Postantimicrobial blood cultures were positive in 63 of 325 (19.4%) patients
Adults with severe manifestations of sepsis,
(systolic BP< 90 mm Hg or serum lactate level > 4 mmol/L)
Intervention:
Blood cultures obtained before and within 120 min after initiation of antimicrobial treatment.
2019
49. MICROBIAL RESISTANCE IN SEPSIS
Sepsis
Need to cover for all
responsible microorganisms
Rapid action
50. MICROBIAL RESISTANCE IN SEPSIS
Sepsis
Need to cover for all
responsible microorganisms
Rapid action
Medico-legal
pressure
51. MICROBIAL RESISTANCE IN SEPSIS
Sepsis
Need to cover for all
responsible microorganisms
Use of broad spectrum
antibiotics
Rapid action
Medico-legal
pressure
52. MICROBIAL RESISTANCE IN SEPSIS
Sepsis
Need to cover for all
responsible microorganisms
Use of broad spectrum
antibiotics
Increase in microbial
resistance
Rapid action
Medico-legal
pressure
53. MICROBIAL RESISTANCE IN SEPSIS
Sepsis
Need to cover for all
responsible microorganisms
Use of broad spectrum
antibiotics
Increase in microbial
resistance
Rapid action
Medico-legal
pressure
54. 2023
Severe Sepsis/Septic Shock Early Management Bundle (SEP-1).
SEP-1 requires hospitals to report adherence to the bundle.
55. 2023
Severe Sepsis/Septic Shock Early Management Bundle (SEP-1).
SEP-1 requires hospitals to report adherence to the bundle.
Including broad-spectrum antibiotics within 3 hours +
at least 30 mL/kg of crystalloids for hypotension or hyperlactatemia.
Hospitals receive credit only if all components are performed
or contraindications documented.
56. 2023
Severe Sepsis/Septic Shock Early Management Bundle (SEP-1).
SEP-1 requires hospitals to report adherence to the bundle.
Four large, rigorous, multicenter time-series analyses document
the disappointing real-world impact of SEP-1 across hundreds of US hospitals.
No change in mortality.
Benefit only in SEP-1–compliant vs noncompliant care (different populations).
Pakyz et al. Clin Infect Dis. 2021;
Rhee et al. JAMA Open. 2021
Barbash et al. Ann Intern Med. 2021
Anderson et al. Clin Infect Dis. 2022
Including broad-spectrum antibiotics within 3 hours +
at least 30 mL/kg of crystalloids for hypotension or hyperlactatemia.
Hospitals receive credit only if all components are performed
or contraindications documented.
57. 2023
Severe Sepsis/Septic Shock Early Management Bundle (SEP-1).
SEP-1 requires hospitals to report adherence to the bundle.
Four large, rigorous, multicenter time-series analyses document
the disappointing real-world impact of SEP-1 across hundreds of US hospitals.
The use of broad-spectrum antibiotics increased. Aggressive fluid resuscitation.
No change in mortality.
Benefit only in SEP-1–compliant vs noncompliant care (different populations).
Pakyz et al. Clin Infect Dis. 2021;
Rhee et al. JAMA Open. 2021
Barbash et al. Ann Intern Med. 2021
Anderson et al. Clin Infect Dis. 2022
Including broad-spectrum antibiotics within 3 hours +
at least 30 mL/kg of crystalloids for hypotension or hyperlactatemia.
Hospitals receive credit only if all components are performed
or contraindications documented.
58. 2023
Severe Sepsis/Septic Shock Early Management Bundle (SEP-1).
SEP-1 requires hospitals to report adherence to the bundle.
Four large, rigorous, multicenter time-series analyses document
the disappointing real-world impact of SEP-1 across hundreds of US hospitals.
The use of broad-spectrum antibiotics increased. Aggressive fluid resuscitation.
No change in mortality.
Benefit only in SEP-1–compliant vs noncompliant care (different populations).
it focuses exclusively on the initial hours of care and lacks incentives
to optimize subsequent care.
Pakyz et al. Clin Infect Dis. 2021;
Rhee et al. JAMA Open. 2021
Barbash et al. Ann Intern Med. 2021
Anderson et al. Clin Infect Dis. 2022
Including broad-spectrum antibiotics within 3 hours +
at least 30 mL/kg of crystalloids for hypotension or hyperlactatemia.
Hospitals receive credit only if all components are performed
or contraindications documented.
62. I give antibiotics as soon as possible….
the more severe the clinical presentation
the more urgent the antibiotic administration
Antibiotic therapy should cover all likely pathogens
Not less – not more!
How I treat septic shock
ANTIBIOTICS
73. This patient needs
to go to the OR
immediately !
Yes, the
anesthesiologist
is on his way
RAPID SOURCE CONTROL
74. This patient needs
to go to the OR
immediately !
Yes, the
anesthesiologist
is on his way
The surgeon
is quickly evaluating
another patient
first
RAPID SOURCE CONTROL
75. This patient needs
to go to the OR
immediately !
Yes, the
anesthesiologist
is on his way
They will call us
as soon as
the OR is ready
The surgeon
is quickly evaluating
another patient
first
RAPID SOURCE CONTROL
76. This patient needs
to go to the OR
immediately !
Yes, the
anesthesiologist
is on his way
They will call us
as soon as
the OR is ready
Shouldn't we
have another CT
first ?
The surgeon
is quickly evaluating
another patient
first
RAPID SOURCE CONTROL
77. Control the source when indicated,
and as soon as possible
How I treat septic shock
I motivate the team!
78. Ventilate
Infuse
Pump
The VIPrule
(Weil and colleagues)
Oxygen administation
mechanical ventilation ?
IV fluids
Blood transfusions ?
Vasopressor agents ?
Dobutamine ?
How I treat septic shock
79. Ventilate
Infuse
Pump
The VIPrule
(Weil and colleagues)
Oxygen administation
mechanical ventilation ?
IV fluids
Blood transfusions ?
Vasopressor agents ?
Dobutamine ?
How I treat septic shock
83. Ventilate Oxygen administation
mechanical ventilation ?
When to intubate the trachea ?
Answer : When the question is raised…
Question :
What are the benefits of mechanical ventilation ?
Question :
Answer : Improved gas exchange
Decreased oxygen requirements (of the respiratory muscles)
(Unloading of the left ventricle)
Severe hypoxemia and/or elevated work of breathing
84. Endotracheal intubation : optimal timing
TIME
Is intubation
avoidable?
Respiratory
arrest
When is
the right time?
85. Endotracheal intubation : optimal timing
TIME
Is intubation
avoidable?
Respiratory
arrest
Dyspnea
RR
Gas exchange
Speech
Consciousness
When is
the right time?
87. The new SSC guidelines offer little leeway for adapting
the recommendations to the idiosyncrasies of each and every patient.
Some allowance for breaking the “one size fits all” guideline mold
that has taken root in the last two decades
would have been a daring but welcome and timely change.
2021
88. We recommend individualizing the need for and timing of tracheal intubation,
based on careful clinical assessment, including level of consciousness, respiratory
rate and work of breathing, hemodynamic status, and assessment of gas exchange.
Delaying tracheal intubation may lead to respiratory and even cardiac arrest, with
dire consequences,
yet premature use of invasive mechanical ventilation can expose the patient to
ventilator-induced lung injury, distant organ complications, and increased risk of
nosocomial lung infection.
2021
92. PaO2/FiO2
Very low Low
Neurological
status
Coma Conscious state
PCO2
Acidemia
(hypercapnic acidosis)
Normal pH
Hemodynamic
status
Altered
tissue perfusion
Normal
tissue perfusion
Endotracheal intubation?
AI in medicine
93. PaO2/FiO2
Very low Low
Neurological
status
Coma Conscious state
PCO2
Acidemia
(hypercapnic acidosis)
Normal pH
Hemodynamic
status
Altered
tissue perfusion
Normal
tissue perfusion
Muscle function
Muscle weakness
Use of accessory muscles
Normal strength
Endotracheal intubation?
AI in medicine
94. PaO2/FiO2
Very low Low
Neurological
status
Coma Conscious state
PCO2
Acidemia
(hypercapnic acidosis)
Normal pH
Hemodynamic
status
Altered
tissue perfusion
Normal
tissue perfusion
Muscle function
Muscle weakness
Use of accessory muscles
Normal strength
Plans for
major surgery
Endotracheal intubation?
Yes No
AI in medicine
97. A recommendation to keep SpO2within the low-normal range of 92–96%
in all critically ill patients
is easily achievable with minimum effort and little cost.
98. A recommendation to keep SpO2within the low-normal range of 92–96%
in all critically ill patients
is easily achievable with minimum effort and little cost.
How I treat septic shock
108. Normal
Blood volume
in the critically ill
(sepsis, surgery, trauma,…)
Hypovolemia
Vasodilation
Fluid requirement is more than correction of hypovolemia
109. Normal
Blood volume
in the critically ill
(sepsis, surgery, trauma,…)
Hypovolemia
Vasodilation
Capillary
leak
Fluid requirement is more than correction of hypovolemia
110. Normal
Blood volume
in the critically ill
(sepsis, surgery, trauma,…)
Hypovolemia
Vasodilation
Hyperdynamic
state
CARDIAC
OUTPUT
FILLING
Capillary
leak
Fluid requirement is more than correction of hypovolemia
121. 250 to 500 ml allowed only in severe hypoperfusion
(lactate >4 mMol/L, MAP < 50 mmHg despite vasopressors, mottling, UO < 0.1 ml/kg/h)
& to ensure a total daily fluid intake of 1 liter.
fluids in fluid – responsive patients
2022
Restrictive
Standard
CLASSIC trial – 1554 patients
122. 250 to 500 ml allowed only in severe hypoperfusion
(lactate >4 mMol/L, MAP < 50 mmHg despite vasopressors, mottling, UO < 0.1 ml/kg/h)
& to ensure a total daily fluid intake of 1 liter.
fluids in fluid – responsive patients
2022
Restrictive
Standard
No difference in any outcome
CLASSIC trial – 1554 patients
125. 2 possible explanations
➢Fluids vs. vasopressors: it does not matter
(you do not need intelligence)
➢Treatment should be personalized
(you do need intelligence)
2023
NO DIFFERENCE
127. 2021
Higher SOFA score and
Higher blood lactate level
on ICU day 3
p
(PROPENSITY SCORE MATCHING)
Immediate
(<1 hour)
Delayed
(>1 hour)
16 hospitals in Korea
vasopressor therapy
128. 2021
Say YES to early vasopressor use
but this should not limit fluid administration!
Higher SOFA score and
Higher blood lactate level
on ICU day 3
p
(PROPENSITY SCORE MATCHING)
Immediate
(<1 hour)
Delayed
(>1 hour)
16 hospitals in Korea
vasopressor therapy
129. Fluid restriction will always reduce edema
(cerebral, pulmonary, cutaneous…)
Fluid restriction may decrease oxygen availability
Fluid restriction may impair healing
Fluid restriction may result in multiple organ failure
FLUID RESTRICTION IS DANGEROUS
130. Fluid restriction will always reduce edema
(cerebral, pulmonary, cutaneous…)
Fluid restriction may decrease oxygen availability
Fluid restriction may impair healing
Fluid restriction may result in multiple organ failure
FLUID RESTRICTION IS DANGEROUS
131. The mean volume infused as boluses on day 1 was
1162 mL (916 mL) for slower infusion vs
1252mL (1009mL) for control infusion rate
Outcomes Comparing Slower (333 mL/h) vs Control (999 mL/h) Infusion Speed
2021
132. The mean volume infused as boluses on day 1 was
1162 mL (916 mL) for slower infusion vs
1252mL (1009mL) for control infusion rate
Outcomes Comparing Slower (333 mL/h) vs Control (999 mL/h) Infusion Speed
2021
133. Conditional Treatment Effect Analysis of Two Infusion Rates
in Critically Ill Patients: BaSICS Trial
FG Zampieri et al., Ann Am Thorac Soc.
2023
10,465 pts
Model trained in 5230 pts
Model tested in 5235 pts
134. Conditional Treatment Effect Analysis of Two Infusion Rates
in Critically Ill Patients: BaSICS Trial
FG Zampieri et al., Ann Am Thorac Soc.
2023
81%
No recommendation
5%
333 mL/h
14%
999 mL/h
10,465 pts
Model trained in 5230 pts
Model tested in 5235 pts
Recommendation
135. Conditional Treatment Effect Analysis of Two Infusion Rates
in Critically Ill Patients: BaSICS Trial
FG Zampieri et al., Ann Am Thorac Soc.
2023
81%
No recommendation
5%
333 mL/h
14%
999 mL/h
10,465 pts
Model trained in 5230 pts
Model tested in 5235 pts
36 years
APACHE II 7
RRT 3.6%
Mortality 7.9%
Recommendation
136. Conditional Treatment Effect Analysis of Two Infusion Rates
in Critically Ill Patients: BaSICS Trial
FG Zampieri et al., Ann Am Thorac Soc.
2023
81%
No recommendation
5%
333 mL/h
14%
999 mL/h
10,465 pts
Model trained in 5230 pts
Model tested in 5235 pts
36 years
APACHE II 7
RRT 3.6%
Mortality 7.9%
79 years
APACHE II 17
RRT 12%
Mortality 46%
Recommendation
139. How do you call it?
Fluid overload? Hypervolemia? Edema
Edema does not exclude hypovolemia!
140. 2018
The terms hypervolemia and fluid overload are often used interchangeably,
yet they do not have the same meaning.
“Fluid overload” may vaguely refer
to excess total body water content associated with edema,
but it would be better if the term were avoided completely.
The word “hypervolemia” is sufficient to indicate an excess in circulating
blood volume and, if present, needs to be properly documented before a
strategy of fluid restriction and/or diuretics is applied.
141.
142. How much fluids?
By formula
Fluid balance / presence of edema
Individualized / Monitoring
151. Does this patient need IV fluid ?
Central venous pressure 6 mmHg maybe
152. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Central venous pressure 6 mmHg maybe
153. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Central venous pressure 6 mmHg maybe
Heart rate 117 / min maybe
154. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Cardiac output 3.9 L/min maybe
Central venous pressure 6 mmHg maybe
Heart rate 117 / min maybe
155. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Cardiac output 3.9 L/min maybe
Urine output 10 mL/h maybe
Central venous pressure 6 mmHg maybe
Heart rate 117 / min maybe
156. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Cardiac output 3.9 L/min maybe
Urine output 10 mL/h maybe
Central venous pressure 6 mmHg maybe
ScvO2 60 % maybe
Heart rate 117 / min maybe
157. Does this patient need IV fluid ?
Arterial pressure 85/45 mmHg maybe
Cardiac output 3.9 L/min maybe
Urine output 10 mL/h maybe
Central venous pressure 6 mmHg maybe
ScvO2 60 % maybe
Heart rate 117 / min maybe
Lactate 3.1 mEq/L maybe
164. Pulse Pressure Variation
(PPV)
Stroke Volume Variation
(SVV)
AP monitoring
CO monitoring
FLUID RESPONSIVENESS
ONLY
During mechanical ventilation
With deep sedation / anesthesia
(without major arrhythmia)
167. No routine sedation for comfort
Use sedative agents only when absolutely required
Sedative agents can have adverse hemodynamic effects
SEDATIVE AGENTS
168. I AVOID SEDATIVE AGENTS
Decreased vascular tone
Decreased myocardial contracility
Risk of delirium
Long term weakness
How I treat septic shock
169. MORE FLUIDS ?
Fluid
challenge
Pulse Pressure Variation (PPV)
Stroke Volume Variation (SVV)
Anesthetized or
Deeply sedated/paralyzed
Spontaneous breathing
(with or without mechanical ventilation)
Fully controlled
mechanival ventilation
End-expiratory pause
Sigh
170. ECHOCARDIOGRAPHY
All cardiac measurements
All diagnosis
Large pericardial effusion / tamponade
Severe valvular dysfunction
LV failure
RV dilatation
Any
medical
doctor
cardiologist
ICU / ER
doctor
171. ECHOCARDIOGRAPHY
All cardiac measurements
All diagnosis
Quantitative assessment of LV function
Mild/moderate valvular dysfunction
Assessment of cardiac output
and pulmonary artery pressures
Reliable assessment of VTI
Large pericardial effusion / tamponade
Severe valvular dysfunction
LV failure
RV dilatation
Any
medical
doctor
cardiologist
ICU / ER
doctor
177. The goal of fluid administration
Increase
in DO2
Improved
tissue perfusion
Increase
in cardiac output
178. The goal of fluid administration
Increase
in DO2
No increase
in edema
Improved
tissue perfusion
Minimal increase
in cardiac filling pressures
Increase
in cardiac output
182. COST
BENEFIT
MORE IV FLUIDS ?
Major increase
in filling
No significant increase
in cardiac output
Minor increase
in filling
Significant increase
in cardiac output
183. COST
BENEFIT
MORE IV FLUIDS ?
Major increase
in filling
No significant increase
in cardiac output
Minor increase
in filling
Significant increase
in cardiac output
CARDIAC
OUTPUT
CARDIAC
FILLING
186. >20 min
in
at least 50%
of the studies
2022
Positive response:
> 15% increase in CO
124 studies
187. TIME should be LIMITED
for two reasons
1- to avoid giving much fluid
in the patient who does not benefit
2- to avoid interferences
from other interventions
Fluid challenge
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
189. TIME, min
CO
Too slow / too long Too small effect
Other influences
on cardiac output
30 min
Fluid challenge
190. TIME, min
CO
Too slow / too long Too small effect
Other influences
on cardiac output
Optimal? (ER/ICU)
CO
5-10 min
30 min
Fluid challenge
191. Fluid challenge
assess assess
Do not change anything (vasoactive agents, …)
Do not suction the trachea…
Do not stimulate the patient…
Do not touch the patient !
Baseline 5-10 min
100 – 200 mL
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
192. Fluid challenge
assess assess
Do not change anything (vasoactive agents, …)
Do not suction the trachea…
Do not stimulate the patient…
Do not touch the patient !
Baseline 5-10 min
100 – 200 mL
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
assess
5-10 min
100 – 200 mL
195. 1 liter in 30 min
What is a
fluid challenge?
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
196. 1 liter in 30 min
What is a
fluid challenge?
200 mL in 5-10 min
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
197. 1 liter in 30 min
What is a
fluid challenge?
200 mL in 5-10 min
200 mL in 5-10 min
Repeat?
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
198. 1 liter in 30 min
What is a
fluid challenge?
200 mL in 5-10 min
200 mL in 5-10 min
200 mL in 5-10 min
Repeat?
Repeat?
Vincent JL & Weil MH, Crit Care Med 34: 1333-7, 2006
Vincent JL, Cecconi M, De Backer D, Crit Care 2020
203. TIME, min
CO
Too slow / too long
EFFECTS OF FLUID BOLUSES
Too small effect
Other influences
on cardiac output
Optimal? (ER/ICU)
CO
5-10 min
30 min
204. TIME, min
CO
Too slow / too long
EFFECTS OF FLUID BOLUSES
Too small effect
Other influences
on cardiac output
Short time (OR)
CO
Optimal? (ER/ICU)
CO
1 min
5-10 min
30 min
205. Too short time
CO
TIME, min
CO
Too slow / too long
EFFECTS OF FLUID BOLUSES
positive response
in any individual
Too small effect
Other influences
on cardiac output
Short time (OR)
CO
Optimal? (ER/ICU)
CO
< 1 min
1 min
5-10 min
30 min
214. 2022
Automatic echo measurement of sub-aortic VTI from a transthoracic apical 5-chamber view.
Correct positioning of the probe + optimal Doppler signal in the left ventricular outflow tract (LVOT): green
VTI
215. Averaging three measurements within one TTE examination
enough for VTI in patients in sinus rhythm
(not in atrial fibrillation).
Between two TTE examinations performed by the same operator,
significant changes in VTI with assessment
of the effects of a 500-mL fluid infusion.
2019
217. Can this patient benefit from fluids ?
Yes, definitely Maybe
Give
fluids
The clinical scenario
e.g. acute bleeding
Fluid loading
218. Can this patient benefit from fluids ?
Yes, definitely Maybe
Give
fluids
Fluid
challenge
The clinical scenario
e.g. acute bleeding
Fluid loading
Positive
response
Negative
response
219. Can this patient benefit from fluids ?
Yes, definitely Maybe
Give
fluids
Fluid
challenge
Do not give
fluids
The clinical scenario
e.g. acute bleeding
Fluid loading
Positive
response
Negative
response
220. Can this patient benefit from fluids ?
Yes, definitely Maybe
Give
fluids
Fluid
challenge
Do not give
fluids
The clinical scenario
e.g. acute bleeding
Fluid loading
Positive
response
Negative
response
221. 143 patients
11 French ICUs
500 mL crystalloids
over 10 min
>15%
increase in VTI 76 (53%)
Fluid responders
37
transient
39
persistent
2019
222. 143 patients
11 French ICUs
500 mL crystalloids
over 10 min
>15%
increase in VTI 76 (53%)
Fluid responders
37
transient
39
persistent
2019
223. PASSIVE LEG RAISING
Is there a transient increase in stroke volume?
yes no
FLUID RESPONSIVENESS NO FLUID RESPONSIVENESS
228. First, PLR should start from the semi-recumbent and not the supine position.
Second, the PLR effects must be assessed by a direct measurement of
cardiac output and not by the simple measurement of blood pressure.
Third, the technique used to measure cardiac output during PLR
must be able to detect short-term and transient changes
since the PLR effects may vanish after1 minute.
Fourth, cardiac output must be measured not only before and during PLR
but also after PLR when the patient has been moved back
to the semi-recumbent position, in order to check that it returns to its baseline.
Fifth, pain, cough, discomfort, and awakening could provoke adrenergic stimulation,
resulting in mistaken interpretation of cardiac output changes.
Some simple precautions must be taken to avoid these confounding factors.
PLR must be performed by adjusting the bed and
not by manually raising the patient’s legs.
229. First, PLR should start from the semi-recumbent and not the supine position.
Second, the PLR effects must be assessed by a direct measurement of
cardiac output and not by the simple measurement of blood pressure.
Third, the technique used to measure cardiac output during PLR
must be able to detect short-term and transient changes
since the PLR effects may vanish after1 minute.
Fourth, cardiac output must be measured not only before and during PLR
but also after PLR when the patient has been moved back
to the semi-recumbent position, in order to check that it returns to its baseline.
Fifth, pain, cough, discomfort, and awakening could provoke adrenergic stimulation,
resulting in mistaken interpretation of cardiac output changes.
Some simple precautions must be taken to avoid these confounding factors.
PLR must be performed by adjusting the bed and
not by manually raising the patient’s legs.
230. First, PLR should start from the semi-recumbent and not the supine position.
Second, the PLR effects must be assessed by a direct measurement of
cardiac output and not by the simple measurement of blood pressure.
Third, the technique used to measure cardiac output during PLR
must be able to detect short-term and transient changes
since the PLR effects may vanish after1 minute.
Fourth, cardiac output must be measured not only before and during PLR
but also after PLR when the patient has been moved back
to the semi-recumbent position, in order to check that it returns to its baseline.
Fifth, pain, cough, discomfort, and awakening could provoke adrenergic stimulation,
resulting in mistaken interpretation of cardiac output changes.
Some simple precautions must be taken to avoid these confounding factors.
PLR must be performed by adjusting the bed and
not by manually raising the patient’s legs.
231. First, PLR should start from the semi-recumbent and not the supine position.
Second, the PLR effects must be assessed by a direct measurement of
cardiac output and not by the simple measurement of blood pressure.
Third, the technique used to measure cardiac output during PLR
must be able to detect short-term and transient changes
since the PLR effects may vanish after1 minute.
Fourth, cardiac output must be measured not only before and during PLR
but also after PLR when the patient has been moved back
to the semi-recumbent position, in order to check that it returns to its baseline.
Fifth, pain, cough, discomfort, and awakening could provoke adrenergic stimulation,
resulting in mistaken interpretation of cardiac output changes.
Some simple precautions must be taken to avoid these confounding factors.
PLR must be performed by adjusting the bed and
not by manually raising the patient’s legs.
235. Can the patient
benefit from IV fluids?
Internal
(Passive Leg Raising)
Fluid
Challenge
External
(200 mL in 10 min)
236. Can the patient
benefit from IV fluids?
Internal
(Passive Leg Raising)
Fluid
Challenge
Increase in stroke volume / cardiac output ?
External
(200 mL in 10 min)
237. Can the patient
benefit from IV fluids?
Internal
(Passive Leg Raising)
Fluid
Challenge
Increase in stroke volume / cardiac output ?
External
(200 mL in 10 min)
Yes No
Do not give
more fluids
238.
239.
240. Type of fluid ?
CRYSTALLOIDS
NaCl 0.9 %
Ringer's lactate
Plasmalyte
…
FLUIDS FOR RESUSCITATION
COLLOIDS
Albumin
HES
Gelatins
…
256. We are not dealing here with a new drug or procedure whose effects need further
exploration in humans. Rather, we are dealing with intravenous solutions whose composition is quite
simple and well known. No-one would dispute that giving large amounts of a solution including 154
mEq/L of chloride will result in hyperchloremia, which cannot be good for the patient. Even without
reviewing in detail all the potentially harmful effects of hyperchloremia, anyone can appreciate that
any electrolyte abnormality can have harmful effects. From the opposite perspective, no-one has
ever suggested that hyperchloremia could be beneficial in any situation.
Giving any kind of fluid in small amounts cannot be very toxic. Saline solutions are cheap and
there is no reason to entirely prohibit their use in all patients. They also have a specific indication in
the management of metabolic alkalosis or hyponatremia. However, it is not good medical practice to
continue to give 0.9% saline solutions when chloride levels increase above the normal range. One
would not do a study comparing crystalloids with or without potassium chloride without monitoring
potassium levels. More generally, one would not give any electrolyte supplementation when levels of
that electrolyte are more than adequate. Any biochemical abnormality is associated with worse
outcomes; why would this be different for chloride? Such RCTs therefore raise ethical questions, as
equipoise is no longer present when patients who have developed hyperchloremia continue to
receive chloride. We would not want to be randomized to that group, as the treatment offered
would represent poor clinical management.
The authors of the SALT trial call for a larger trial on this question: they would be wise to
abandon their plans and, instead, start to monitor chloride levels in their patients.
2017
257. We are not dealing here with a new drug or procedure whose effects need further
exploration in humans. Rather, we are dealing with intravenous solutions whose composition is quite
simple and well known. No-one would dispute that giving large amounts of a solution including 154
mEq/L of chloride will result in hyperchloremia, which cannot be good for the patient. Even without
reviewing in detail all the potentially harmful effects of hyperchloremia, anyone can appreciate that
any electrolyte abnormality can have harmful effects. From the opposite perspective, no-one has
ever suggested that hyperchloremia could be beneficial in any situation.
Giving any kind of fluid in small amounts cannot be very toxic. Saline solutions are cheap and
there is no reason to entirely prohibit their use in all patients. They also have a specific indication in
the management of metabolic alkalosis or hyponatremia. However, it is not good medical practice to
continue to give 0.9% saline solutions when chloride levels increase above the normal range. One
would not do a study comparing crystalloids with or without potassium chloride without monitoring
potassium levels. More generally, one would not give any electrolyte supplementation when levels of
that electrolyte are more than adequate. Any biochemical abnormality is associated with worse
outcomes; why would this be different for chloride? Such RCTs therefore raise ethical questions, as
equipoise is no longer present when patients who have developed hyperchloremia continue to
receive chloride. We would not want to be randomized to that group, as the treatment offered
would represent poor clinical management.
The authors of the SALT trial call for a larger trial on this question: they would be wise to
abandon their plans and, instead, start to monitor chloride levels in their patients.
2017
272. VASOPRESSOR SUPPORT IN SEPTIC SHOCK
" Vasopressor support is added
when hypotension persisted
despite fluid administration."
273. VASOPRESSOR SUPPORT IN SEPTIC SHOCK
" Vasopressor support is added
when hypotension persisted
despite fluid administration."
Not ideal
274. VASOPRESSOR SUPPORT IN SEPTIC SHOCK
" Vasopressor support is added
when hypotension persisted
despite fluid administration."
Not ideal
If hypotension is severe,
vasopressor therapy
should be started immediately,
together with fluid administration.
296. THE MESSAGE
A MAP >75 mmHg
may be optimal in some patients
(history of hypertension)
A MAP of 65 mmHg for all?
A MAP <65 mmHg
may be acceptable in some patients
(even if older than 65 years)
It can be the INITIAL target
310. We recommend
an initial target mean arterial pressure (MAP) of 65 mm Hg
in patients with septic shock requiring vasopressors.
Grade 1 B
SEPSIS
SURVIVING CAMPAIGN
2016
Crit Care Med 2017
Intensive Care Med 2017
VASOPRESSOR AGENTS
311. We recommend
an initial target mean arterial pressure (MAP) of 65 mm Hg
in patients with septic shock requiring vasopressors.
Grade 1 B
SEPSIS
SURVIVING CAMPAIGN
2016
Crit Care Med 2017
Intensive Care Med 2017
VASOPRESSOR AGENTS
Remarks:
If initiated, vasopressor dosing should be titrated
to an end point reflecting perfusion…
313. We recommend individualizing arterial blood pressure levels.
Although a mean value of 65 mmHg may be recommended as an
initial goal, the optimal level may be higher in patients with a
history of hypertension, atherosclerosis or chronic kidney disease.
Conversely it may be lower in younger patients without previous
vascular problems, in those with chronically low arterial pressure,
or in whom adequate tissue perfusion is maintained.
2021
315. What is the target blood pressure in shock ?
60
70
80
90
?
Young,
No atherosclerosis
Chronically low blood pressure
Elderly
Atherosclerosis
Chronic hypertension
Mean
arterial
pressure
INITIAL target = 65 mmHg
then REASSESS
316. What is the target blood pressure in shock ?
60
70
80
90
?
Young,
No atherosclerosis
Chronically low blood pressure
Elderly
Atherosclerosis
Chronic hypertension
Diuresis ?
Mental status ?
Skin perfusion ?
+
cardiac output?
SvO2? Lactate?
Mean
arterial
pressure
INITIAL target = 65 mmHg
then REASSESS
317. What is the target blood pressure in shock ?
60
70
80
90
Arterial
pressure
100
50
40
318. What is the target blood pressure in shock ?
60
70
80
90
Arterial
pressure
100
50
40
Vasopressors
are probably needed
Vasopressors
may or may not be needed
341. VASOPRESSIN
DOSES
Increased vascular tone
Increased urine output (?)
Less edema formation
Maybe ?
No !
0.05 U/min
0.10 U/min
HYPERKINETIC STATE
Decreased cardiac output
Excessive vasoconstriction
Impaired hepato-splanchnic perfusion
Reduced coronary blood flow
Pulmonary hypertension
342. Need for vasopressors
Oliguria / altered mentation/cutaneous vasoconstriction
Increased lactate levels
CI < 3 L/min.M²
ScvO2 < 70%
CI > 3 L/min.M²
ScvO2 > 70%
SHOCK
343. Need for vasopressors
Oliguria / altered mentation/cutaneous vasoconstriction
Increased lactate levels
CI < 3 L/min.M²
ScvO2 < 70%
CI > 3 L/min.M²
ScvO2 > 70%
Fluid challenge
SHOCK
344. Need for vasopressors
Oliguria / altered mentation/cutaneous vasoconstriction
Increased lactate levels
CI < 3 L/min.M²
ScvO2 < 70%
CI > 3 L/min.M²
ScvO2 > 70%
Fluid challenge
Increase in CI
No major Increase in filling
OK ?
SHOCK
345. Need for vasopressors
Oliguria / altered mentation/cutaneous vasoconstriction
Increased lactate levels
CI < 3 L/min.M²
ScvO2 < 70%
CI > 3 L/min.M²
ScvO2 > 70%
Fluid challenge
No increase in CI
Increase in filling
Increase in CI
No major Increase in filling
Dobutamine
Vasodilators ?
Transfusion ?
OK ?
SHOCK
346. Need for vasopressors
Oliguria / altered mentation/cutaneous vasoconstriction
Increased lactate levels
CI < 3 L/min.M²
ScvO2 < 70%
CI > 3 L/min.M²
ScvO2 > 70%
Fluid challenge
No increase in CI
Increase in filling
Increase in CI
No major Increase in filling
Dobutamine
Vasodilators ?
Transfusion ?
OK ?
SHOCK
354. In the recent trials
Less severely ill
Higher initial ScvO2 (already in the target range)
Improved early resuscitation?
Higher patient selection
Less commonly treated by mech. ventilation
Lower mortality rate
Not all needed ICU admission
Enrolment primarily during office hours
(but greater benefit outside these hours?)
356. THE MESSAGE
Systematic maintenance of SvO2 above 70% (EGDT)
is naïve and potentially harmful
(too much fluids, transfusions, dobutamine)
SvO2 measurements can be helpful
BUT
357. THE MESSAGE
Systematic maintenance of SvO2 above 70% (EGDT)
is naïve and potentially harmful
(too much fluids, transfusions, dobutamine)
in prolonged septic shock
after resuscitation
(when you become short of ideas)
SvO2 measurements can be helpful
BUT
373. Endotracheal
intubation?
SpO2 95-98%
Saline
If no severe acidemia
If hyponatremia
Oxygen
Balanced
solution
If severe acidemia
If hypernatremia
If hyperchloremia
1 liter
fast
Ventilate Infuse Pump
374. Endotracheal
intubation?
SpO2 95-98%
Saline
If no severe acidemia
If hyponatremia
Measure Cl
If < 105 mEq/L If > 105 mEq/L
Oxygen
Balanced
solution
If severe acidemia
If hypernatremia
If hyperchloremia
1 liter
fast
Ventilate Infuse Pump
375. Endotracheal
intubation?
SpO2 95-98%
Saline
If no severe acidemia
If hyponatremia
Measure Cl
If < 105 mEq/L If > 105 mEq/L
Oxygen
Balanced
solution
If severe acidemia
If hypernatremia
If hyperchloremia
1 liter
fast
Albumin
If edema
If hypoalbuminemia
Ventilate Infuse Pump
380. Endotracheal
intubation?
SpO2 95-98%
Oxygen
Insert
a CVC
1 liter
fast
To be repeated?
Insert
an
arterial
catheter
If profound
sedation
Fluid
challenge
PLR test
Measure
SV/CO
Look at
PPV / SVV
Use a
cardiac output
monitor
Ventilate Infuse Pump
Norepinephrine
Start early
if profound
hypotension
381. Endotracheal
intubation?
SpO2 95-98%
Oxygen
Insert
a CVC
1 liter
fast
Fluid
challenge
Excessive
vasoconstriction?
Dobutamine
3-5 mcg/kg/min
ScvO2 >70%?
Need for transfusion? (check Hb)
Is lactate level decreasing?
Ventilate Infuse Pump
To be repeated?
Norepinephrine
Start early
if profound
hypotension
398. Conclusions:
Better outcome associated with decreasing blood lactate concentrations
- consistent throughout the clinical studies
- not limited to septic patients
- valid regardless of the initial value
- in all groups, changes relatively slow, so that
lactate measurements every 1–2 hrs are probably sufficient
in most acute conditions.
2016
407. We must monitor blood lactate levels
(every hour in critical periods)
SEPSIS MANAGEMENT
Practical aspects
(not to GUIDE therapy)
To make sure we are on the right track
408. HEMODYNAMIC STABILIZATION
Adequate MAP without vasopressors
The three windows of tissue perfusion
Lactate levels normal or decreasing
Normal skin perfusion
Urine output > 0.5 mL/kg/h
Preserved mental status
The goals
418. TRAUMA
Insert
a central venous catheter
Insert
a Foley catheter
Order blood
Send blood
for coagulation tests
Call the surgeon
Let us go
to the CT-scanner
Do an echo
Call for imaging
Call the OR
Insert
a NG tube
Ask for
a head CT-scan
Send
other lab tests
Give another liter
of RL solution
Give another unit
of RBC
Intubate
the trachea
Call
the orthopedist surgeon
!
!
!
!
!
!
! !
!
!
!
!
!
!
!
!
!
!
!
!
!
419. TRAUMA
Insert
a central venous catheter
Insert
a Foley catheter
Order blood
Send blood
for coagulation tests
Call the surgeon
Let us go
to the CT-scanner
Do an echo
Call for imaging
Call the OR
Insert
a NG tube
Ask for
a head CT-scan
Send
other lab tests
Give another liter
of RL solution
Give another unit
of RBC
Intubate
the trachea
Call
the orthopedist surgeon
!
!
!
!
!
!
! !
!
!
!
!
!
!
!
!
!
!
!
!
!
SEPSIS
420. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
TRAUMA
421. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
TRAUMA
SEPSIS
422. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
423. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
echography
Diagnostic
techniques
chest
X ray
call for
CT-scan
424. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
echography
Diagnostic
techniques
chest
X ray
Blood
tests
ABG – lactate
cell count
urea/BUN - creatinine
coagulation panel…
call for
CT-scan
425. The 5 tubes
central venous
catheter
arterial catheter
Foley catheter
gastric tube
endotracheal
tube
echography
Diagnostic
techniques
chest
X ray
Blood
tests
ABG – lactate
cell count
urea/BUN - creatinine
coagulation panel…
Microbiology
blood cultures urine
culture
sputum
drainage
fluid
call for
CT-scan
439. SHOCK LAB
4 3 2 1
Dept
of
Intensive Care
Dept
of
Emergency
Medicine
Erasme Univ. Hospital
(University of Brussels)
Piagnerelli M, Vannuffelen M, Maetens Y, Lheureux P, Vincent JL
Anaesth Intensive Care 37: 426-31, 2009
440. SHOCK LAB
4 3 2 1
Dept
of
Intensive Care
Dept
of
Emergency
Medicine
Erasme Univ. Hospital
(University of Brussels)
Piagnerelli M, Vannuffelen M, Maetens Y, Lheureux P, Vincent JL
Anaesth Intensive Care 37: 426-31, 2009
STAFF
441. SHOCK LAB
Piagnerelli M, Vannuffelen M, Maetens Y, Lheureux P, Vincent JL
Anaesth Intensive Care 37: 426-31, 2009
442. SHOCK LAB
Piagnerelli M, Vannuffelen M, Maetens Y, Lheureux P, Vincent JL
Anaesth Intensive Care 37: 426-31, 2009
443. SHOCK LAB
Piagnerelli M, Vannuffelen M, Maetens Y, Lheureux P, Vincent JL
Anaesth Intensive Care 37: 426-31, 2009
449. “golden hour”
R. Adams Cowley,
Founder of the Trauma Institute, Baltimore
(1975)
“the first hour after injury will largely determine
a critically injured person's chances for survival”
TRAUMA